Quote:

---

It is either of no significance and they just decided to list every indication we are going for kicks (despite them telling us very recently that many of these were on the back burner until we had revenue)

---

I have to admit, there's the slightest tinge of something compensatory in that agenda list. Almost as though they are going to remind us of all of our other indications (even though they are all stalled for one reason or another) as a technique to deflect away from something else -- enrollment shortcomings? I don't know -- I certainly hope that is not true. Over the past couple of days, with the NEJM report on remdesivir and the WHO report on hydroxychloroquine, I've been feeling that the stars are in alignment and all we need to do is finish these trials ASAP and we're off-to-the-races. It's time to save lives.